Treatment of occipital neuralgia using onabotulinum toxin A.

Isabela Maria Garcia Marcolla Carlos Henrique Ferreira de Camargo Léo Coutinho Matheus Gomes Ferreira Alex Tiburtino Meira Elcio Juliato Piovesan Hélio Augusto Guizoni Teive

Published in: Acta neurologica Scandinavica (2021)

Our findings suggest onabotulinum toxin type A is a safe and effective treatment alternative for patients suffering from refractory greater occipital nerve neuralgia.

Keyphrases

escherichia coli
end stage renal disease
newly diagnosed
peritoneal dialysis
patient reported outcomes